Drug survival studies have been utilized to evaluate the real-world effectiveness of biologics
used in psoriasis. However, the increasing volume of drug survival data suffers from large …

Drug survival of biologics represents their real-world effectiveness and safety. We conducted
a meta-analysis of real-world evidence on the drug survival of biologics in treating psoriasis …

Drug survival measures the length of time until discontinuation of a drug. The length of time
a patient remains on a biologic drug is impacted by several factors such as tolerability, side …

Abstract Background/Objectives Data on biologic drug survival in real‐world psoriasis
treatment are limited. There is a need to evaluate long‐term trends of biologic use outside …

Drug survival reflects a drug's effectiveness, safety, and tolerability. We assessed the drug
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …

The real-world efficacy of biologics may be insufficiently assessed through common drug
survival studies. The objective was thus to examine the real-world performance of biologics …

Background Real‐world biologic drug survival is an important proxy measure for
effectiveness. Predictors of drug survival may help patients with psoriasis choose between …

Little is known about the drug survival of second-line biologic therapies for psoriasis in
routine clinical practice. We assessed drug survival of second-line biologic therapies and …

This is a Japanese retrospective single‐center study carried out between 1 January 2010
and 21 November 2018 at the Department of Dermatology in Jichi Medical University …

Background Drug survival is defined as the time period of treatment with a certain drug until
its cessation. The role of previous exposure to traditional systemic treatments in biologic …